Edition:
India

Zhejiang ChiMin Pharmaceutical Co Ltd (603222.SS)

603222.SS on Shanghai Stock Exchange

14.97CNY
12:29pm IST
Change (% chg)

¥0.03 (+0.20%)
Prev Close
¥14.94
Open
¥14.98
Day's High
¥15.03
Day's Low
¥14.87
Volume
936,392
Avg. Vol
3,005,632
52-wk High
¥18.30
52-wk Low
¥13.80

Latest Key Developments (Source: Significant Developments)

Zhejiang Chimin Pharmaceutical signs cooperation agreement with AIMIS
Monday, 23 Oct 2017 

Oct 23(Reuters) - Zhejiang Chimin Pharmaceutical Co Ltd <603222.SS> ::Says it signed a cooperation agreement with AIMIS, a U.S. based minimally invasive surgery research institute firm, to make a contribution on Chinese clinical studies .  Full Article

Zhejiang Chimin Pharma to acquire stake, boost capital in hospital
Friday, 5 Aug 2016 

Zhejiang Chimin Pharmaceutical Co Ltd <603222.SS> :Says it plans to acquire 80 percent stake in a hospital and to boost its capital for a combined 360 million yuan ($54.18 million).  Full Article

Zhejiang Chimin Pharmaceutical to pay 2015 dividend on June 21
Wednesday, 15 Jun 2016 

Zhejiang Chimin Pharmaceutical Co., Ltd. <603222.SS> : Says it will pay a cash dividend of 0.65 yuan (before tax) per 10 shares and use additional paid-in capital to distribute 10 new shares for every 10 shares for 2015, to shareholders of record on June 20 .Says the company's shares will be traded ex-right and ex-dividend on June 21 and the dividend will be paid on June 21.  Full Article

Zhejiang Chimin Pharma plans to acquire Spain's Linear Chemicals
Monday, 23 May 2016 

Zhejiang Chimin Pharmaceutical Co Ltd <603222.SS> :Says it plans to acquire Spain's Linear Chemicals S.L., In Vitro Diagnostics (IVD) products manufacturer, for 4.99 million euros ($5.59 million).  Full Article

Zhejiang ChiMin Pharmaceutical announces 2015 dividend payment
Thursday, 28 Apr 2016 

Zhejiang ChiMin Pharmaceutical Co Ltd:Says it will pay a cash dividend of 0.65 yuan (pre-tax) for every 10 shares, and use additional paid-in capital to distribute 10 new shares for every 10 shares, to shareholders for 2015.  Full Article